respiratory medicine

Product Name: Maxiflo 125 Inhaler 120 MDI Manufacturer: Cipla Ltd (India) Formulation: Pressurised Metered-Dose Inhaler (MDI) Pack Size: 120 metered doses (120 MD) Active Ingredients (per actuation) : Fluticasone Propionate — 125 mcg – A corticosteroid that reduces airway inflammation. Formoterol Fumarate — 6 mcg – A long-acting β₂-agonist (LABA) that relaxes airway muscles. The combination provides anti-inflammatory and bronchodilator effects used for long-term control of asthma and COPD symptoms. Indications : Asthma: For regular maintenance treatment (not for acute attacks). Chronic Obstructive Pulmonary Disease (COPD): Helps reduce symptoms like wheezing, shortness of breath, and chest tightness. Not a rescue inhaler: It is not suitable for sudden worsening of symptoms. Usage & Administration : Route: Inhalation. Typical Dose (Adults): Usually 1–2 inhalations twice daily, as prescribed by a doctor. Shake well before use and rinse mouth after inhalation to help prevent oral thrush Asthma Management: Long-term control and prevention of symptoms like wheezing, chest tightness, and shortness of breath. COPD Treatment: Helps manage symptoms associated with chronic bronchitis and emphysema. Bronchospasm Relief: Opens airways to make breathing easier. Prevention: Helps prevent exercise-induced asthma. Maxiflo 125 mcg Inhaler (120 MDI) is a combination prescription medication containing Fluticasone Propionate (a steroid) and Formoterol Fumarate (a bronchodilator) used to treat asthma and Chronic Obstructive Pulmonary Disease (COPD). It reduces airway inflammation and relaxes muscle passages to relieve wheezing, coughing, and breathing difficulties.